John A. Orwin - Insider Trading & Ownership

Entity
Individual
Location
C/O Relypsa, Inc., 700 Saginaw Dr., Redwood City, California
Summary
The estimated net worth of John A. Orwin is at least $271K dollars as of June 18, 2024. John A. Orwin is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $195K. John A. Orwin is the Director of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $47.1K. John A. Orwin is the PRESIDENT & CEO, Director of Atreca, Inc. and owns shares of Atreca, Inc. stock worth about $29K.
All Insider Reports
All Insider Reports

Ownership of John A. Orwin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TVTX Travere Therapeutics, Inc. Director $195K May 8, 2024
ANAB ANAPTYSBIO, INC Director $47.1K Jun 15, 2024
BCEL Atreca, Inc. PRESIDENT & CEO, Director $29K -$8.6K -22.8% Apr 11, 2024
CRGX CARGO Therapeutics, Inc. Director Jun 4, 2024
SGEN Seagen Inc. Director Dec 14, 2023

Insider Transactions Reported by John A. Orwin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.